Fenretinide in Treating Patients With Recurrent Malignant Glioma
Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of fenretinide in treating patients who
have recurrent malignant glioma.
Phase:
Phase 2
Details
Lead Sponsor:
North American Brain Tumor Consortium Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins